Owen N. Witte, Director at Allogene Therapeutics, Inc. (ALLO), sold 5,000 shares at $25.54 ($128K) on 2021-09-09, disclosed to the SEC on 2021-09-09.
Open-market sale of $128k ALLO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALLO | SELL | 2021-08-23 | $351K | — | Filing → |
| ALLO | SELL | 2021-06-11 | $499K | — | Filing → |
| ALLO | BUY | 2018-10-17 | $270K | — | Filing → |